Showing results (1491-1500 of 1,859) with videos related to

Sort By:
Pageof 186
JAMA Ophthalmology|November 15, 2019
Validation of the Postnatal Growth and Retinopathy of Prematurity Screening CriteriaGil Binenbaum, Lauren A Tomlinson, Alejandra G de Alba Campomanes, et al.
JAMA Ophthalmology|November 8, 2019
Secondary 12-Month Ocular Outcomes of a Phase 1 Dosing Study of Bevacizumab for Retinopathy of PrematurityEric R Crouch, Raymond T Kraker, David K Wallace, et al.
JAMA Ophthalmology|February 1, 2019
Predictors of Spectacle Wear and Reasons for Nonwear in Students Randomized to Ready-made or Custom-made Spectacles: Results of Secondary Objectives From a Randomized Noninferiority TrialPriya Morjaria, Jennifer Evans, Clare Gilbert
JAMA Ophthalmology|February 8, 2019
Immune Response and Intraocular Inflammation in Patients With Leber Hereditary Optic Neuropathy Treated With Intravitreal Injection of Recombinant Adeno-Associated Virus 2 Carrying the ND4 Gene: A Secondary Analysis of a Phase 1/2 Clinical TrialCéline Bouquet, Catherine Vignal Clermont, Anne Galy, et al.
JAMA Ophthalmology|December 20, 2019
Association of Genetic Variation With KeratoconusBennet J McComish, Srujana Sahebjada, Yelena Bykhovskaya, et al.
JAMA Ophthalmology|February 21, 2020
Glaucoma Care of Prison Inmates at an Academic HospitalLevi N Kanu, Inae Jang, Daniel J Oh, et al.
JAMA Ophthalmology|February 21, 2020
Long-term Effect of Intraocular Lens vs Contact Lens Correction on Visual Acuity After Cataract Surgery During Infancy: A Randomized Clinical TrialScott R Lambert, George Cotsonis, Lindreth DuBois, et al.
JAMA Ophthalmology|February 7, 2020
Ciliary Body Mass as a Feature of Ocular SarcoidosisHoneylen Maryl Tiu Teo, Susan G Elner, Thérèse Maria Peron Sassalos, et al.
JAMA Ophthalmology|February 7, 2020
Association of Visit Adherence and Visual Acuity in Patients With Neovascular Age-Related Macular Degeneration: Secondary Analysis of the Comparison of Age-Related Macular Degeneration Treatment TrialMeera S Ramakrishnan, Yinxi Yu, Brian L VanderBeek
JAMA Ophthalmology|January 10, 2020
Cost-effectiveness of Intravitreal Ranibizumab With Verteporfin Photodynamic Therapy Compared With Ranibizumab Monotherapy for Patients With Polypoidal Choroidal VasculopathyBrett Doble, Eric Andrew Finkelstein, Yubing Tian, et al.
Pageof 186